Tünde Minier

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst et al. · The Lancet Respiratory Medicine · 2020 · 612 citations · Full text

Autoimmune Disease, Systemic Scleroderma, Immunology +3

Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis

Tünde Minier, Serena Guiducci, Silvia Bellando-Randone et al. · Annals of the Rheumatic Diseases · 2013 · 215 citations

The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index

Gabriele Valentini, Michele Iudici, Ulrich A. Walker et al. · Annals of the Rheumatic Diseases · 2016 · 215 citations · Full text

Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS)

Silvia Bellando-Randone, Francesco Del Galdo, Gemma Lepri et al. · The Lancet Rheumatology · 2021 · 129 citations

Clinical Finding, Disease Progression, Longitudinal Registry Study +8

Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis.

Gabór Kumánovics, Tünde Minier, Judit Radics et al. · PubMed · 2008 · 71 citations